أعضاء هيئة التدريس - جامعة بنها
Assessment of Liver Fatty Acid Binding Protein (L-FABP) as a Diagnostic Marker in Non-Alcoholic Fatty Liver Disease
• 2019
معلومات البحث
المؤلفون
Badawy A. Abdulaziz1*, Sabry Anis Abdu1, Ahmed Mostafa Amin2,
Ahmed Khayri Abdel Hamid El Menyawi3, Abdelmoneam Ahmed4, Medhat A. Khalil4,
Walid A. Abdel Halim5
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Assessment of Liver Fatty Acid Binding Protein
(L-FABP) as a Diagnostic Marker in
Non-Alcoholic Fatty Liver Diseaseng/sensitivity, specificity, PPV, NPV and accuracy were 90%,
How to cite this paper: Abdulaziz, B.A.,
Abdu, S.A., Amin, A.M., El Menyawi,
A.K.A.H., Ahmed, A., Khalil, M.A. and
Halim, W.A.A. (2019) Assessment of Liver
Fatty Acid Binding Protein (L-FABP) as a
Diagnostic Marker in Non-Alcoholic Fatty
Liver Disease. Open Journal of Gastroenterology, 9, 113-124.
https://doi.org/10.4236/ojgas.2019.96014
Received: May 9, 2019
Accepted: June 25, 2019
Published: June 28, 2019
Copyright © 2019 by author(s) and
Scientific Research Publishing Inc.
This work is licensed under the Creative
Commons Attribution International
License (CC BY 4.0).
http://creativecommons.org/licenses/by/4.0/
Open Access
B. A. Abdulaziz et al.
DOI: 10.4236/ojgas.2019.96014 114 Open Journal of Gastroenterology
90%, 95.4%, 95.4%, 88.9% with AUC was 0.950. Conclusion: Serum L-FABP
could be used as a new diagnostic biomarker for detecting NAFLD.
(L-FABP) as a Diagnostic Marker in
Non-Alcoholic Fatty Liver Diseaseng/sensitivity, specificity, PPV, NPV and accuracy were 90%,
How to cite this paper: Abdulaziz, B.A.,
Abdu, S.A., Amin, A.M., El Menyawi,
A.K.A.H., Ahmed, A., Khalil, M.A. and
Halim, W.A.A. (2019) Assessment of Liver
Fatty Acid Binding Protein (L-FABP) as a
Diagnostic Marker in Non-Alcoholic Fatty
Liver Disease. Open Journal of Gastroenterology, 9, 113-124.
https://doi.org/10.4236/ojgas.2019.96014
Received: May 9, 2019
Accepted: June 25, 2019
Published: June 28, 2019
Copyright © 2019 by author(s) and
Scientific Research Publishing Inc.
This work is licensed under the Creative
Commons Attribution International
License (CC BY 4.0).
http://creativecommons.org/licenses/by/4.0/
Open Access
B. A. Abdulaziz et al.
DOI: 10.4236/ojgas.2019.96014 114 Open Journal of Gastroenterology
90%, 95.4%, 95.4%, 88.9% with AUC was 0.950. Conclusion: Serum L-FABP
could be used as a new diagnostic biomarker for detecting NAFLD.